Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo

被引:329
作者
Bottger, A [1 ]
Bottger, V [1 ]
Sparks, A [1 ]
Liu, WL [1 ]
Howard, SF [1 ]
Lane, DP [1 ]
机构
[1] UNIV DUNDEE,CANC RES CAMPAIGN LABS,DUNDEE DD1 4HN,SCOTLAND
关键词
D O I
10.1016/S0960-9822(06)00374-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The transcriptional activation function of the p53 tumour suppressor protein is induced by DNA damage and results in growth arrest and/or apoptotic responses. A key component of this response is the dramatic rise in p53 protein concentration resulting from an increase in the protein's stability. Very recently, it has been suggested that interaction with the Mdm2 protein may target p53 for rapid degradation. We have designed a gene encoding a small protein that binds tightly to the p53-binding pocket on the Mdm2 protein. We have constructed the gene by cloning a phage display optimised MdmP-binding peptide into the active-site loop of thioredoxin. Results: When introduced into cells containing low levels of wild-type p53, this protein causes a striking accumulation of the endogenous p53 protein, activation of a p53-responsive reporter gene, and cell cycle arrest mimicking the effects seen in these cells after exposure to UV or ionising radiation. Microinjection of a monoclonal antibody to the p53-binding site on Mdm2 achieves a similar effect, establishing its specificity. Conclusions: These results demonstrate that the p53 response is constitutively regulated in normal cells by Mdm2 and that disruption of the interaction alone is sufficient to stabilise the p53 protein and activate the p53 response. Our mini protein approach provides a powerful new method to activate p53 without causing DNA damage. More broadly, it establishes a powerful general method for determining the biological consequences of the specific disruption of protein-protein interactions in cells.
引用
收藏
页码:860 / 869
页数:10
相关论文
共 30 条
  • [1] HIGH-FREQUENCY DEVELOPMENTAL ABNORMALITIES IN P53-DEFICIENT MICE
    ARMSTRONG, JF
    KAUFMAN, MH
    HARRISON, DJ
    CLARKE, AR
    [J]. CURRENT BIOLOGY, 1995, 5 (08) : 931 - 936
  • [2] MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY
    BARAK, Y
    JUVEN, T
    HAFFNER, R
    OREN, M
    [J]. EMBO JOURNAL, 1993, 12 (02) : 461 - 468
  • [3] Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2
    Blaydes, JP
    Gire, V
    Rowson, JM
    WynfordThomas, D
    [J]. ONCOGENE, 1997, 14 (15) : 1859 - 1868
  • [4] Molecular characterization of the hdm2-p53 interaction
    Bottger, A
    Bottger, V
    GarciaEcheverria, C
    Chene, P
    Hochkeppel, HK
    Sampson, W
    Ang, K
    Howard, SF
    Picksley, SM
    Lane, DP
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 269 (05) : 744 - 756
  • [5] Bottger V, 1996, ONCOGENE, V13, P2141
  • [6] INTERACTIONS BETWEEN P53 AND MDM2 IN A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY
    CHEN, CY
    OLINER, JD
    ZHAN, QM
    FORNACE, AJ
    VOGELSTEIN, B
    KASTAN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2684 - 2688
  • [7] Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2
    Colas, P
    Cohen, B
    Jessen, T
    Grishina, I
    McCoy, J
    Brent, R
    [J]. NATURE, 1996, 380 (6574) : 548 - 550
  • [8] THE MDM-2 ONCOGENE CAN OVERCOME WILD-TYPE P53 SUPPRESSION OF TRANSFORMED-CELL GROWTH
    FINLAY, CA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) : 301 - 306
  • [9] MDM2 GENE AMPLIFICATION AND TRANSCRIPT LEVELS IN HUMAN SARCOMAS - RELATIONSHIP TO TP53 GENE STATUS
    FLORENES, VA
    MAELANDSMO, GM
    FORUS, A
    ANDREASSEN, A
    MYKLEBOST, O
    FODSTAD, O
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) : 1297 - 1302
  • [10] Mdm2 promotes the rapid degradation of p53
    Haupt, Y
    Maya, R
    Kazaz, A
    Oren, M
    [J]. NATURE, 1997, 387 (6630) : 296 - 299